From 1 July 2025, an announcement adding nizines, trifluoroetomidate and 12 other substances to the non-medical narcotic drug supplement catalogue also covered hexahydrocannabinol (HHC). HHC is a semi-synthetic cannabinoid; the 2025 edition of the non-medical catalogue lists it with natural cannabis, resin, extracts, dronabinol and delta-9 THC. The change puts HHC products in the same controlled category as other non-medical narcotics.[1][2]
Listed for context. No score change is recorded for China here.
References
- 长沙晚报 — 长沙通报打击毒品犯罪审判情况并发布典型案例（2025年6月26日）六氢大麻酚等列入非药用类麻醉药品和精神药品管制品种增补目录，2025年7月1日生效
- CMS — Cannabis law and legislation in China (updated 23 July 2026)Medical use: Catalogue of Non-Medical Narcotic Drugs and Psychotropic Substances (2025 version)archived
Checked. The date and the event were compared with a source that was read.